Trends Archives

Sales Training Trends

July 9, 2018

Duct Tape for Learning

Duct tape is renowned for its use in patching up repairs because of its ability…

Jan Ananian

Love0

Trends

November 14, 2017

5 Instructional Design Trends Impacting Pharmaceutical Sales Training

My daughter has been coming home from school each day full of questions that I’m…

Julie Swasey

Love0

Sales Training Trends

October 11, 2017

What you need to know: The evolving pharma sales force

What you need to know: The evolving pharma sales force BioPharmaDive article written by Lisa LaMotta…

Mark Currier

Love0

The average investment for a first indication launch was $13 million, with an average maximum spend of $20 million across the 12 pharma companies surveyed, which included Pfizer, Amgen, Bayer, Novartis and Eli Lilly.

Best Practices / Beth Snyder Bulik

Tools for Trainers Trends

June 16, 2017

Machine Learning for Pharma Sales Training

Machine learning and artificial intelligence (AI) are often used interchangeably, but there are subtle differences.…

Mark Currier

Love0

Learning Science Sales Training Trends

April 14, 2017

Train the Brain: Understanding How the mPFC Relates to Sales Training

The medial prefrontal cortex (mPFC) is a structure in the brain of a rat, but…

Mark Currier

Love0

Tools for Trainers Featured Sales Training Trends

June 24, 2013

5 TED Talks Sales Trainers Should Watch

As a sales training professional in the pharmaceutical or medical device space, you should be…

Mark Currier

Love0

Trends

February 13, 2017

2016 Novel New Drugs Approved Infographic

Novel new drug approvals in 2016 were half of what they were in 2015. How…

Mark Currier

Love0

e-learning Sales Training Trends

March 19, 2013

Tele-detailing…a call from the future of pharma sales?

"Tele-what", you may ask? "That can't be what I think it is." And yet, it…

Mary Calvagna

Love0

Sales Training Trends

October 5, 2016

Personalized Versus Adaptive Learning

Adaptive learning isn’t new, in fact, it’s been around for quite a while. Though it…

Ellen Simes

Love0

Trends

The average investment for a first indication launch was $13 million, with an average maximum spend of $20 million across the 12 pharma companies surveyed, which included Pfizer, Amgen, Bayer, Novartis and Eli Lilly.

Categories